Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass

The New England Journal of Medicine
K LindpaintnerD Levy

Abstract

Homozygous carries of the D allele of the angiotensin-converting-enzyme (ACE) gene have been reported to be at increased risk for various cardiovascular disorders, including left ventricular hypertrophy. We investigated the potential role of the ACE gene in influencing left ventricular mass. Quantitative echocardiographic data and DNA samples were available for 2439 subjects from the Framingham Heart Study. ACE genotypes were determined by an assay based on the polymerase chain reaction. (The D allele of the ACE gene contains a deletion, whereas the I [insertion] allele does not.) Left ventricular mass and the prevalence of left ventricular hypertrophy, adjusted for clinical covariates, were analyzed according to genotype. Genetic linkage between the ACE locus and left ventricular mass was evaluated by quantitative analysis of pairs of siblings. The ACE genotype was associated neither with left ventricular mass nor with the prevalence of left ventricular hypertrophy. Mean (+/-SE) left ventricular mass (adjusted for sex) among subjects carrying the DD, DI, and II genotypes was 165+/-1.6, 165+/-1.3, and 166+/-2.0 g, respectively (P=0.90). The prevalence of left ventricular hypertrophy among the three genotype groups was 15.6 perc...Continue Reading

References

Sep 1, 1979·American Journal of Epidemiology·W B KannelW P Castelli
Jul 1, 1990·American Journal of Hypertension·G A HarshfieldS J Anderson
Apr 1, 1990·Clinical and Experimental Pharmacology & Physiology·B FabrisC I Johnston
Jan 1, 1989·Genetic Epidemiology·C I AmosJ E Bailey-Wilson
Apr 15, 1987·The American Journal of Cardiology·D LevyW P Castelli
Feb 11, 1988·Nucleic Acids Research·S A MillerH F Polesky
Dec 1, 1987·The American Journal of Cardiology·R FagardA Amery
Jul 5, 1985·JAMA : the Journal of the American Medical Association·F LandryJ Dumesnil
Jul 2, 1973·European Journal of Biochemistry·M Gross-BellardP Chambon
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J M PfefferE Braunwald
Aug 1, 1981·Archives of Internal Medicine·T GordonT R Dawber
Jan 15, 1995·Circulation·K SchwartzM Komajda
Mar 16, 1995·The New England Journal of Medicine·K LindpaintnerC H Hennekens
Sep 1, 1994·The American Journal of Cardiology·M S LauerD Levy
Aug 1, 1993·Journal of the American College of Cardiology·J M SullivanD M Mirvis
Feb 1, 1993·Journal of Molecular and Cellular Cardiology·K LindpaintnerH Drexler
Mar 1, 1951·American Journal of Public Health and the Nation's Health·T R DAWBERF E MOORE

❮ Previous
Next ❯

Citations

Jul 9, 2009·JAMA : the Journal of the American Medical Association·Ramachandran S VasanStefan Blankenberg
Nov 16, 2001·Journal of Molecular and Cellular Cardiology·C SemsarianJ G Seidman
Mar 24, 2004·Diabetes Research and Clinical Practice·Yumiko SakkaYasuhiko Iwamoto
Nov 6, 2001·The American Journal of Cardiology·V J DzauUNKNOWN Working Group on Tissue Angiotensin-converting enzyme, International Society of Cardiovascular Pharmacotherapy
Jan 12, 2001·Journal of the American College of Cardiology·R E SchmiederV Regitz-Zagrosek
Feb 1, 1997·Journal of the American College of Cardiology·F PerticoneP L Mattioli
Jul 27, 1999·The Journal of Steroid Biochemistry and Molecular Biology·P C WhiteM Kupari
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·Jop H van Berlo, Yigal M Pinto
Dec 12, 2001·European Journal of Clinical Investigation·F DietM Böhm
Jul 16, 1999·Clinical and Experimental Pharmacology & Physiology·F C Luft
Dec 3, 2002·Diabetes Technology & Therapeutics·David W Moskowitz
Jul 14, 2011·Genetic Testing and Molecular Biomarkers·Sevgi YimeniciogluMehmet Yavuz Coskun
Mar 14, 2003·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Yoon-Ho ChoiSang Chul Park
Oct 9, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Tsung-Hsien LinSheng-Hsiung Sheu
Nov 17, 2004·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Gysèle S BleuminkBruno H Ch Stricker
Jul 14, 2009·Journal of Hypertension·Donna K ArnettUlrich Broeckel
May 1, 1997·Clinical and Experimental Pharmacology & Physiology·S TamakiA Mori
Feb 1, 2006·Clinical and Experimental Pharmacology & Physiology·Tatiana TsoutsmanChristopher Semsarian
Nov 7, 2001·Alcoholism, Clinical and Experimental Research·O A KajanderP J Karhunen
Jan 1, 1997·Annual Review of Physiology·T Matsusaka, I Ichikawa
Sep 28, 2004·American Journal of Respiratory and Critical Care Medicine·Ling LinEmmanuel Mignot
Jan 5, 2002·Hypertension Research : Official Journal of the Japanese Society of Hypertension·E N ObinecheA M Bokhari
May 17, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yuxiao FuToshio Ogihara
Sep 6, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Mohammad SaeedPhilippe M Frossard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.